- Home
- SFM vs ROIV Comparison
SFM vs ROIV Comparison
Compare SFM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFM
- ROIV
- Stock Information
- Founded
- SFM 2002
- ROIV 2014
- Country
- SFM United States
- ROIV United Kingdom
- Employees
- SFM N/A
- ROIV N/A
- Industry
- SFM Food Chains
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- SFM Consumer Staples
- ROIV Health Care
- Exchange
- SFM Nasdaq
- ROIV Nasdaq
- Market Cap
- SFM 16.2B
- ROIV 7.8B
- IPO Year
- SFM 2013
- ROIV N/A
- Fundamental
- Price
- SFM $164.46
- ROIV $11.62
- Analyst Decision
- SFM Buy
- ROIV Buy
- Analyst Count
- SFM 13
- ROIV 4
- Target Price
- SFM $166.85
- ROIV $17.50
- AVG Volume (30 Days)
- SFM 2.6M
- ROIV 7.9M
- Earning Date
- SFM 07-30-2025
- ROIV 08-07-2025
- Dividend Yield
- SFM N/A
- ROIV N/A
- EPS Growth
- SFM 53.52
- ROIV N/A
- EPS
- SFM 4.43
- ROIV N/A
- Revenue
- SFM $8,071,918,000.00
- ROIV $29,053,000.00
- Revenue This Year
- SFM $14.82
- ROIV $3.28
- Revenue Next Year
- SFM $11.05
- ROIV $156.84
- P/E Ratio
- SFM $36.06
- ROIV N/A
- Revenue Growth
- SFM 15.51
- ROIV N/A
- 52 Week Low
- SFM $80.69
- ROIV $8.73
- 52 Week High
- SFM $182.00
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- SFM 45.16
- ROIV 54.55
- Support Level
- SFM $157.04
- ROIV $10.71
- Resistance Level
- SFM $165.80
- ROIV $11.58
- Average True Range (ATR)
- SFM 5.67
- ROIV 0.29
- MACD
- SFM -0.45
- ROIV 0.00
- Stochastic Oscillator
- SFM 29.25
- ROIV 62.16
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.